移动医疗在老年2型糖尿病患者中的临床应用  

Clinical application of mobile telemedicine in the elderly patients with type 2 diabetes mellitus

作　　者：邓玉凤[1] 王海民 彭若萱 张红[1] 许琴 冯亚坤 孙琳[1] 王欢[1] 王桂侠[1] 孙成林[1] 

机构地区：[1]吉林大学第一医院内分泌代谢科,长春130021

出　　处：《中华内分泌代谢杂志》2017年第10期841-844,共4页Chinese Journal of Endocrinology and Metabolism

基　　金：吉林省财政厅科学技术项目（20152017）,吉林省教育厅科学技术项目（JJKH20170842KJ）

摘　　要：从本科门诊就诊的60岁以上2型糖尿病患者中筛选91例，试验组用具有数据传输功能的血糖仪传送血糖数据，获得医疗组药物、饮食、运动等糖尿病＂M-健康＂（Mobile-Health）远程综合管理，对照组维持传统的门诊就诊模式，不予额外干预，2组间隔3个月接受定期随访。结果显示，3个月后，试验组的餐后2 h血糖较对照组明显改善（P〈0.05）。6个月时，与基线相比，试验组餐后2 h血糖及HbA1C水平呈阶段性下降，与对照组相比具有统计学意义（P〈0.05）。提示基于智能手机的糖尿病远程综合管理有助于老年2型糖尿病患者的血糖控制。Ninety-one patients over 60 year old with type 2 diabetes mellitus （T2DM） were selected from our outpatient department. The patients of experimental group uploaded their blood glucose data detected with glucometers, and obtained integrated management called ＂ Mobile Health（M-health）＂ management such as medicines, diet, exercise from medical groups. The patients of control group got medical care in a traditional way without receiving other interventions. Regular follow-up was conducted in 2 groups every 3 months. The results showed that 3 months later, postprandial 2h plasma glucose in the experimental group was significantly improved compared with that of control group （P〈0.05）. Six months later, postprandial 2h plasma glucose and HbA1C levels in the experimental group showed a decline comparing to the baseline, showing a statistical significance compared with control group （P〈0.05）. These results suggest that smartphone-based telemedicine is helpful of blood glucose control in elderly T2DM patients.

关 键 词：老年糖尿病 移动医疗 M-健康管理 

分 类 号：R587.1[医药卫生—内分泌]